Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease
Top Cited Papers
Open Access
- 25 August 2015
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American College of Cardiology
- Vol. 132 (8), 624-632
- https://doi.org/10.1161/circulationaha.114.014807
Abstract
Background—Apixaban is approved for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. However, the ARISTOTLE trial included a substantial number of patients with valvular heart disease and only excluded patients with clinically significant mitral stenosis or mechanical prosthetic heart valves.This publication has 20 references indexed in Scilit:
- Surgery for Valvular Heart Disease: A Population-Based Study in a Brazilian Urban CenterPLOS ONE, 2012
- Antithrombotic Therapy for Atrial Fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Apixaban versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2011
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)European Heart Journal, 2010
- Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationaleAmerican Heart Journal, 2010
- Dabigatran versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2009
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005
- VALVE DISEASE: Worldwide perspective of valve diseaseHeart, 2000
- Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimatesThe American Journal of Cardiology, 1998
- Cerebral embolism and mitral stenosis: survival with and without anticoagulantsJournal of Neurology, Neurosurgery & Psychiatry, 1974